By Andrew McIntosh ( October 23, 2018, 1:57 PM EDT) -- Significant amendments to the Patented Medicines (Notice of Compliance) Regulations came into force in September 2017. A purpose of these Regulations is to ensure that manufacturers of generic or biosimilar medicines do not receive marketing authorization before addressing patents that the innovator of the medicine maintains on a “patent list.”...